1-4 of 4
Xi Li
Close
Sort by
Journal Articles

Efficacy and Safety of New Anti-CD20 Monoclonal Antibodies Versus Rituximab for Induction Therapy of CD20 + B-Cell Non-Hodgkin Lymphomas: A Systematic Review and Meta-Analysis

Chengxin Luo, Xi Li, Shuangnian Xu, Jieping Chen
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-139157
Published: 2020
Journal Articles

Factors Associated with Survival and Severe Cytokine Release Syndrome of Patients with Relapsed/Refractory B-ALL Receiving CD19 CAR-T Cell Therapy

Xi Li, Chengxin Luo, Shuangnian Xu, Yanni Ma, Jieping Chen
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-139254
Published: 2020
Journal Articles

Elavl1a regulates zebrafish erythropoiesis via posttranscriptional control of gata1

Xi Li, Yi-Chien Lu, Kezhi Dai, Ingrid Torregroza, Timothy Hla, Todd Evans
Journal: Blood
Blood (2014) 123 (9): 1384–1392.
https://doi.org/10.1182/blood-2013-09-526962
Published: 2014
Includes: Supplemental data
Journal Articles

Protein kinase Cδ mediates retinoic acid and phorbol myristate acetate–induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation

Ke-Wen Zhao, Xi Li, Qian Zhao, Ying Huang, Dong Li, Zhen-Gang Peng, Wu-Zhong Shen, Ji Zhao, Quansheng Zhou, Zhu Chen, Peter J. Sims, Therese Wiedmer, Guo-Qiang Chen
Journal: Blood
Blood (2004) 104 (12): 3731–3738.
https://doi.org/10.1182/blood-2004-04-1630
Published: 2004